Lawyer Kyle Diamantas appointed FDA’s acting leader as concerns mount over hantavirus outbreak
Market News Today — AI-Curated Stock & Crypto Headlines
Filters active
Daily Market Digest (Sep 4, 2026) 🤖 AI-Powered
Today’s market developments reflect a mix of geopolitical shifts, sector-specific catalysts, and corporate actions.
Trending Evidence Watch
High-confidence AI observations with source context and evaluated outcome tracking
No High-Impact Observations
Check back soon or explore latest news below for developing stories.
Search Results for "FDA" (142 articles)
Makary's tenure was marked by internal dysfunction at the FDA, leadership turmoil and mounting backlash from drugmakers and physicians on …
International Biotechnology Trust (LSE:IBT) co-lead fund managers Ailsa Craig and Marek Poszepczynski tell Proactive's Stephen gunnion that the trust delivered …
Eli Lilly and Company (NYSE:LLY) is one of the 10 Strong Buy S&P 500 Stocks to Invest In. On May …
The studies were "withdrawn because the authors drew broad conclusions that were not supported by the underlying data," the spokesperson …
U.S. Food and Drug Administration Commissioner Marty Makary, under pressure, defends himself in an interview with CNBC's David Faber.
The Food and Drug Administration has recorded two ‘serious’ cases in patients taking Eli Lilly’s weight-loss pill.
FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence.
FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence.
FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence.
FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence.
FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence.
Market Insight
Multi-Provider AI Analysis
AI Summary
Loading...
Market Context
Analysis powered by multiple AI providers with automatic fallback for reliability- Loading...